合鍛智能(603011.SH):減持期過半 股東段啟掌累計減持1%股份
格隆匯2月17日丨合鍛智能(603011.SH)公佈,截至2021年12月2日,股東段啟掌通過集中競價方式累計減持公司股份450萬股,佔公司非公開發行股票前總股本的1%。此後截至2022年2月17日,段啟掌未減持公司股份,本次減持計劃減持時間已過半,減持計劃尚未實施完畢。
公司因實施非公開發行股票,總股本增加,段啟掌未參加本次股票發行的認購,導致其在持股數量不變的情況下,持股比例被動稀釋。發行完成後段啟掌先生及其一致行動人持有公司股份23,440,080股,持股比例由5.2211%降至4.6435%,不再是公司持股5%以上股東。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.